Perspective Therapeutics GAAP EPS of -$0.29 beats by $0.01, revenue of $0.29M beats by $0.12M

1 hour ago 1

Perspective Therapeutics press release (NYSE:CATX): Q2 GAAP EPS of -$0.29 beats by $0.01.
Revenue of $0.29M (-45.3% Y/Y) beats by $0.12M.
Cash, cash equivalents and short-term investments of approximately $192M as of June 30, 2025 expected to be sufficient to fund current planned clinical milestones and operational investments into late 2026.

Recommended For You